John Auer and Auer rods; controversies revisited

Area of Science:

• Hematology
• Oncology
• Cell Biology

Background:

• Auer rods are intracytoplasmic inclusions observed in myeloid leukemia cells, first described by John Auer in 1906.
• These unique structures are pathognomonic for myeloid neoplasms, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
• Their presence is exclusively associated with neoplastic conditions, distinguishing them from normal hematopoietic cells.

Discussion:

• This article reviews the historical context of Auer rod discovery and examines ongoing scientific debates surrounding their significance.
• It critically evaluates the inclusion of Auer rods in the World Health Organization (WHO) classification of myelodysplastic syndromes, specifically for refractory anemia with excess of blasts-2 (RAEB-2).
• The discussion highlights the diagnostic and prognostic implications of Auer rods in myeloid malignancies.

Key Insights:

• Auer rods are reliable indicators of myeloid neoplasia, absent in non-neoplastic conditions.
• The diagnostic criteria for certain myelodysplastic syndromes, such as RAEB-2, are re-examined in light of Auer rod presence.
• Understanding Auer rods is crucial for accurate classification and diagnosis of myeloid leukemias and MDS.

Outlook:

• Further research may refine the role of Auer rods in the molecular classification of myeloid neoplasms.
• Clarifying the diagnostic utility of Auer rods can improve patient stratification and treatment strategies.
• Continued investigation into the pathogenesis of Auer rods may offer new therapeutic targets.